US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

317.20

+12.294.03%

Pre-market: 318.120.9200+0.29%05:11 EDT

Volume:468.50K

Turnover:149.84M

Market Cap:673.89M

PE:- -

High:329.20

Open:311.70

Low:306.27

Close:304.91

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.98

T/O Rate:22.05%

Dividend:1.02

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bernstein Keeps Their Buy Rating on Humana (HUM)

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)

BTIG Remains a Buy on Cerus (CERS)

OUE Healthcare (Catalist:5WA) Stock Faces Widening Losses As Speculation Builds

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)

Distinct Healthcare Holdings (SEHK:2677) Stock Looks Cheap Until One Off Gains Fade

Simply Wall St.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)

Analysts Offer Insights on Healthcare Companies: Kyntra Bio (KYNB) and Minerva Neurosciences (NERV)

Analysts’ Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

Foundation Healthcare posts strong 1H 2026 growth and accelerates regional expansion

Health Care Down on Cyclical Bias - Health Care Roundup

Vital Healthcare Manager Ceases to Be Substantial Holder in Property Trust

Press Release: Elutia Secures up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results

Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":317.2,"timestamp":1787342400000,"preClose":304.91,"halted":0,"volume":468504,"hourTrading":{"tag":"盘前","latestPrice":318.12,"preClose":317.2,"latestTime":"05:11 EDT","volume":374,"amount":119147.4614,"timestamp":1787562716148,"change":0.92,"changeRate":0.0029,"amplitude":0.013225},"delay":0,"changeRate":0.04030697582893301,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Pre-Mkt","change":12.29,"latestTime":"08-24 05:37:24 EDT","open":311.7,"high":329.2026,"low":306.27,"amount":149839169.98896,"amplitude":0.075211,"askPrice":321.12,"askSize":16,"bidPrice":316.6,"bidSize":3,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.0032,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":318.12,"preClose":317.2,"latestTime":"05:11 EDT","volume":374,"amount":119147.4614,"timestamp":1787562716148,"change":0.92,"changeRate":0.0029,"amplitude":0.013225},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":0.9815516107169615,"impliedVol":0.9442,"impliedVolPercentile":0.672},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9815516107169615,"shares":2124486,"dividePrice":1.015,"high":329.2026,"amplitude":0.075211,"preClose":304.91,"low":306.27,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":317.2,"committee":-0.684211,"eps":0,"divideRate":0.0032,"volume":468504,"delay":0,"ttmEps":0,"open":311.7,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":276.54,"twentyDayClose":245.6,"sixtyDayClose":186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659149469","title":"Bernstein Keeps Their Buy Rating on Humana (HUM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149469","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149469?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:18","pubTimestamp":1786709904,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes maintained a Buy rating on Humana today and set a price target of $425.00. Wilkes covers the Healthcare sector, focu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0070302665.USD","XBI","HUM","LU0390134368.USD","LU0266013472.USD","LU1983260115.SGD","BK4154","BK4566","BK4581","LU0417517546.SGD","BK4533","SG9999014005.SGD","LU1093756325.SGD","BK4585","BK4588","IHF","LU0320765489.SGD","LU1093756168.USD","SG9999014013.SGD","LU0208291251.USD","LU0170899867.USD","FXH","LABU","SG9999014021.USD","XLV","LU0256863811.USD","LU0238689110.USD","LU0211331839.USD","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149886","title":"Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149886?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:01","pubTimestamp":1786708866,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mediwound (MDWD) and Relay Therapeutics (RLAY) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-relay-therapeutics-rlay-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-relay-therapeutics-rlay-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","RLAY","XLV","BK4139","BK4563","LABU","LU0128526141.USD","XBI","BK4581","BK4137","MDWD","BK4007","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146599","title":"BTIG Remains a Buy on Cerus (CERS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146599?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:36","pubTimestamp":1786707378,"startTime":"0","endTime":"0","summary":"In a report released today, Mark Massaro from BTIG reiterated a Buy rating on Cerus, with a price target of $4.00. Massaro covers the Healthcare se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4198","CERS","XLV","XBI","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144729","title":"OUE Healthcare (Catalist:5WA) Stock Faces Widening Losses As Speculation Builds","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144729","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144729?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:32","pubTimestamp":1786707174,"startTime":"0","endTime":"0","summary":"OUE Healthcare’s stock has been on a speculative tear in recent months, yet it closed at just S$0.039 on Friday as investors absorbed another loss making half. The headline is not revenue; the story is the profit squeeze. H1 2026 revenue sat at S$75.21m, but the company reported a net loss of S$15.23m that widened sharply versus the prior year period and pulled trailing 12 month losses to S$29.66m.\nToday’s muted price suggests the market is still more captivated by the cheap P/S tag than by...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/healthcare/catalist-5wa/oue-healthcare-shares/news/oue-healthcare-catalist5wa-stock-faces-widening-losses-as-sp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/healthcare/catalist-5wa/oue-healthcare-shares/news/oue-healthcare-catalist5wa-stock-faces-widening-losses-as-sp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","AIPO","5WA.SI","XBI","LJ3.SI","BK6098","BK4581","XLV","BK6512","BK6511","BK6092","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128145","title":"Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128145?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:20","pubTimestamp":1786706410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pharvaris (PHVS), Caribou Biosciences (CRBU) and Ave...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-caribou-biosciences-crbu-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-caribou-biosciences-crbu-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CRBU","BK4581","XLV","PHVS","BK4539","BK4585","BK4196","AVAH","BK4139","BK4007","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659450421","title":"Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2659450421","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659450421?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"First patient dosed in an outpatient setting, discharged the same day; multiple patients in the process of screening at several activated sites Trial advances FT819 toward a potential accelerated regu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345223/24675/en/fate-therapeutics-initiates-potentially-registrational-reclaim-ln-clinical-trial-of-ft819-for-the-treatment-of-lupus-nephritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","CAR","BK4022","BK4077","BK4139","GDOC","MEDX","FATE","NVIB","BK4230","HYLG","IDNA","SLE","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145865","title":"Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145865","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"US$9.5 million as of June 30, 2026, increased from US$4.1 million as of. -- Cash and cash equivalents nearly doubled to US$3.65 million, up from. -- Total shareholders' equity increased to US$6.09 million, up approximately. 19% from US$5.10 million at December 31, 2025, reflecting a strengthened. -- Working capital improved significantly to approximately US$1.66 million. as of June 30, 2026, up from approximately US$0.42 million at December. 31, 2025, indicating strengthened short-term liquidity and full coverage. -- Quick ratio of 1.19 as of June 30, 2026, compared to 1.06 as of December. divided by current liabilities), confirming robust liquidity even on a. December 31, 2025. Importantly, approximately 47% of current liabilities,items, reflecting the Company's strong balance sheet management.Reduced Cash Burn and Cost Discipline-- Total operating expenses decreased by 53% in the second quarter of 2026. compared to the same period in 2025, to US$2.29 million from US$4.85. -- General ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","KBWB","LCIZ","LU2264538146.SGD","LU1244550221.USD","LU2357305700.SGD","LU0390134368.USD","LU1548497426.USD","LU0912757837.SGD","LU0006306889.USD","IND","BK4596","LU1244550494.USD","TM","LCDL","LU0234570918.USD","03160","LCID","LU2089283258.USD","REZ","BK4551","LU0098860793.USD","LU1791710400.SGD","BK4581","LU0210528500.USD","LU1732800096.USD","LU2023251221.USD","BK4516","BK4585","LU2133065610.SGD","LU0314104364.USD","LU1989772923.USD","IAI","LU0158827948.USD","LU1732799900.SGD","LU0053666078.USD","LABU","BK4127","LU1244550577.SGD","LU2111349929.HKD","BK4099","LU0106261372.USD","LU1791710582.SGD","LU0795875169.SGD","LU1988902786.USD","LU0267386448.USD","VMRK","QNTM","LU0106831901.USD","IE00B775SV38.USD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414358","title":"Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414358?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:40","pubTimestamp":1786704009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mdxhealth-mdxh-opko-health-opk-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mdxhealth-mdxh-opko-health-opk-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4581","MDXH","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4139","BK4137","LU0128526141.USD","OPK","LABU","ZBIO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659417051","title":"Distinct Healthcare Holdings (SEHK:2677) Stock Looks Cheap Until One Off Gains Fade","url":"https://stock-news.laohu8.com/highlight/detail?id=2659417051","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659417051?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:22","pubTimestamp":1786702929,"startTime":"0","endTime":"0","summary":"Distinct Healthcare Holdings went into this earnings print with a stock that has drifted over the past quarter, down about 10% over 30 days, and only marginally higher over the past week. The headline this time is earnings quality. Reported profit over the last year includes a sizeable one off gain of C¥108.0m, which flatters both earnings per share and the headline P/E of 9.8x against a higher Hong Kong healthcare sector average. The market is now deciding how much of that apparent value in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2677/distinct-healthcare-holdings-shares/news/distinct-healthcare-holdings-sehk2677-stock-looks-cheap-unti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2677/distinct-healthcare-holdings-shares/news/distinct-healthcare-holdings-sehk2677-stock-looks-cheap-unti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","FEBU","02677","VGFPF","GXDW","XLV","BK4581","XBI","BK1209","JOYT","LABU","VOTE","PMDE","DECU","BK4137","RGLO","LU0029874061.USD","HCSG","LU0128526141.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117015","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659117015?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:40","pubTimestamp":1786700431,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrod...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-caribou-biosciences-crbu-bristol-myers-squibb-bmy-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-caribou-biosciences-crbu-bristol-myers-squibb-bmy-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4007","LU0882574055.USD","LU2242646821.SGD","LU1093756325.SGD","LU0321505439.SGD","LU1670710661.SGD","SDGR","LU0237698245.USD","IHE","LU1093756168.USD","LU2242652126.USD","XBI","LU1430594728.SGD","LU0985481810.HKD","LU1983299246.USD","LU1074936037.SGD","LU2596442595.SGD","LU1585245621.USD","LU0225284248.USD","LU0267386448.USD","LU1032466523.USD","LU0096364046.USD","XLV","LU1291159041.SGD","LABU","LU1571399168.USD","LU0306807586.USD","BK4139","LU2125154778.USD","BK4539","LU2125154935.USD","BK4559","LU1261432733.SGD","IE0009355771.USD","BK4532","LU0456855351.SGD","BMY","LU1868837300.USD","LU1989771016.USD","LU1670710588.SGD","BK4588","CRBU","IE00BSNM7G36.USD","LU0321505868.SGD","HCSG","LU0868494617.USD","LU1670711040.USD","IE00B2B36J28.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659186112","title":"Analysts Offer Insights on Healthcare Companies: Kyntra Bio (KYNB) and Minerva Neurosciences (NERV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659186112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659186112?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:00","pubTimestamp":1786698042,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kyntra Bio (KYNB) and Minerva Neurosciences (NERV). Kyntra Bio (K...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kyntra-bio-kynb-and-minerva-neurosciences-nerv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kyntra-bio-kynb-and-minerva-neurosciences-nerv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","LU0029874061.USD","NERV","KYNB","HCSG","BK4137","XLV","LU0128526141.USD","BK4585","LABU","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112995","title":"Analysts’ Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112995?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:50","pubTimestamp":1786697404,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC) and Kuros Biosciences (CSBTF) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alcon-alc-kuros-biosciences-csbtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alcon-alc-kuros-biosciences-csbtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1804176565.USD","XBI","BK4581","BK4139","BK4137","LU2265009873.SGD","ALC","BK4585","BK4588","HCSG","LU0128526141.USD","BK4198","CSBTF","LU0029874061.USD","LABU","XLV","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156611","title":"Foundation Healthcare posts strong 1H 2026 growth and accelerates regional expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156611","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156611?lang=en_us&edition=fundamental","pubTime":"2026-08-14 14:22","pubTimestamp":1786688535,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Foundation Healthcare Holdings Limited ( ($SG:FHH) ). Foundation Healthcare reported first-half 2026 revenue gr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/foundation-healthcare-posts-strong-1h-2026-growth-and-accelerates-regional-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/foundation-healthcare-posts-strong-1h-2026-growth-and-accelerates-regional-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","SG","BK4581","BK4209","BK4585","XLV","XBI","BK4137","BK4588","HCSG","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160096","title":"Health Care Down on Cyclical Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160096","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160096?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:03","pubTimestamp":1786654980,"startTime":"0","endTime":"0","summary":"Health-care companies ticked down as traders rotated back into cyclical sectors after relatively benign inflation data.Roche Holdings is pushing forward with a longstanding plan to enter the gene-sequencing business, 10 years after a failed takeover bid for Illumina.The Food and Drug Administration granted emergency-use authorization to Zoetis for a drug that treats New World screwworm infestations in dogs and puppies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","LABU","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160719","title":"Vital Healthcare Manager Ceases to Be Substantial Holder in Property Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160719?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:47","pubTimestamp":1786654034,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) has provided an update. Vital Healthcare Properties Management Limited has disclosed that it no longer hold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-manager-ceases-to-be-substantial-holder-in-property-trust?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-manager-ceases-to-be-substantial-holder-in-property-trust?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","LABU","XBI","BK4585","BK4588","HCSG","LU0029874061.USD","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659624541","title":"Press Release: Elutia Secures up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659624541","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659624541?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651800,"startTime":"0","endTime":"0","summary":"-- Funded through launch: secured up to $26 million of capital without an. -- The unmet need is real: 86% of surgeons surveyed say the matrices they. NXT-41x; 92% responded they would champion it at their hospital value. -- On track: NXT-41 FDA clearance decision expected in 4Q 2026; NXT-41x FDA. \"We believe we are now funded through the anticipated. clearance and full commercial launch of NXT-41x, our. and launch, surgeon interest in NXT-41x has exceeded. to execute.\"Capital Secured to Support NXT-41x Through Clearance and Commercial LaunchElutia has secured up to $26 million of additional capital to support the Company through the anticipated clearance of NXT-41x and its first full year of commercial launch in 2028, without an equity offering:-- $15 million credit facility, including $10 million funded at closing and. an additional $5 million available following NXT-41x FDA clearance. and commercial milestone paymentsIn addition, the Company anticipates receiving the full $8 million ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1059921491.USD","LU1983299162.USD","LU0302445910.USD","LU2506951792.HKD","IE00B19Z3B42.SGD","LU0124384867.USD","LU0058720904.USD","ELUT","LU2275660780.HKD","BK4139","CI","LU1261432733.SGD","LABU","TAN","LU0724618433.USD","ICLN","IE00BSNM7G36.USD","LU1978683503.SGD","LU2357125470.USD","FRNW","LU2294711713.HKD","LU0823414478.USD","BK4196","VCLN","LU0289739699.SGD","LU2249611893.SGD","LU2298322129.HKD","IE0002270589.USD","CTEC","LU0312595415.SGD","LU0868494617.USD","NXT","BK4596","IE00B19Z3581.USD","BK4585","LU0728928796.USD","LU0053671581.USD","LU0823414551.USD","BK4096","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659857162","title":"Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2659857162","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659857162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651260,"startTime":"0","endTime":"0","summary":"Company launches Flora Sync LF5, the company's first directly commercialized product, began generating revenue in July DARE to PLAY Sildenafil Cream progressing toward national dispensing and initial ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344879/30757/en/dar%C3%A9-bioscience-reports-second-quarter-2026-results-and-highlights-commercial-inflection-as-multi-product-women-s-health-strategy-advances.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4584","BK4007","LABU","BK4588","DARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659668161","title":"Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659668161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659668161?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:00","pubTimestamp":1786644021,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV) and Idexx Laboratories ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-achieve-life-sciences-achv-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-achieve-life-sciences-achv-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GB00B4QBRK32.GBP","IDXX","LABU","BK4504","LU0690374961.EUR","XLV","BK4567","LU0170899867.USD","LU0029874061.USD","LU2404859667.USD","HCSG","ACHV","LU0128526141.USD","GB00B4LPDJ14.GBP","LU2404859741.USD","LU0345774631.USD","BK4581","LU1941712264.USD","LU1291159041.SGD","LU1941712348.USD","BK4082","BK4585","BK4588","XBI","LU1989771016.USD","LU0690374615.EUR","BK4139","BK4137","PAWZ","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659691971","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659691971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659691971?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:20","pubTimestamp":1786641612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LABU","LNSR","XLV","BK4581","BK4082","LU0029874061.USD","BK4585","BK4588","XBI","BK4139","BK4137","HCSG","CADL","LU0128526141.USD","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169563","title":"Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169563?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:50","pubTimestamp":1786639807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE) and Mediwound (MDWD). Fat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4581","XBI","BK4137","BK4588","BK4139","LU0029874061.USD","HCSG","BK4585","LABU","FATE","LU0128526141.USD","XLV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":12,"totalSize":389,"code":"91000000","status":"200"}]}}